Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease

被引:15
|
作者
Alschuler, Lise [1 ,2 ]
Chiasson, Ann Marie [1 ,2 ]
Horwitz, Randy [1 ,2 ]
Sternberg, Esther [1 ,2 ]
Crocker, Robert [1 ,2 ]
Weil, Andrew [2 ,3 ]
Maizes, Victoria [1 ,2 ]
机构
[1] Univ Arizona, Coll Med, Tucson, AZ 85721 USA
[2] Andrew Weil Ctr Integrat Med, Tucson, AZ 85711 USA
[3] Univ Arizona, Tucson, AZ 85721 USA
关键词
Integrative medicine; COVID-19; Immune; Diet; Supplements; Osteopathic manipulation; Qigong; Exercise; Stress reduction; Creative expression; Aromatherapy; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; FUNCTIONAL RECEPTOR; PHYSICAL HEALTH; IMMUNE FUNCTION; LUNG-FUNCTION; DOUBLE-BLIND; EXERCISE; QIGONG; SLEEP;
D O I
10.1016/j.explore.2020.12.005
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The majority of individuals infected with SARS-CoV-2 have mild-to-moderate COVID-19 disease. Convalescence from mild-to-moderate (MtoM) COVID-19 disease may be supported by integrative medicine strategies. Integrative Medicine (IM) is defined as healing-oriented medicine that takes account of the whole person, including all aspects of lifestyle. Integrative medicine strategies that may support recovery from MtoM COVID-19 are proposed given their clinically studied effects in related conditions. Adoption of an antiinflammatory diet, supplementation with vitamin D, glutathione, melatonin, Cordyceps, Astragalus and garlic have potential utility. Osteopathic manipulation, Qigong, breathing exercises and aerobic exercise may support pulmonary recovery. Stress reduction, environmental optimization, creative expression and aromatherapy can provide healing support and minimize enduring trauma. These modalities would benefit from clinical trials in people recovering from COVID-19 infection. (c) 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页码:140 / 148
页数:9
相关论文
共 50 条
  • [41] Impact of COVID-19 on 'Living Well' with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort
    Clare, Linda
    Martyr, Anthony
    Gamble, Laura D.
    Pentecost, Claire
    Collins, Rachel
    Dawson, Eleanor
    Hunt, Anna
    Parker, Sophie
    Allan, Louise
    Burns, Alistair
    Hillman, Alexandra
    Litherland, Rachael
    Quinn, Catherine
    Matthews, Fiona E.
    Victor, Christina
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 85 (02) : 925 - 940
  • [42] Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study
    Jang, Young Rock
    Oh, Yoon Ju
    Kim, Jin Yong
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2022, 96
  • [43] A Pilot of a Randomized Control Trial of Melatonin and Vitamin C for Mild-to-Moderate COVID-19
    Fogleman, Corey
    Cohen, Donna
    Mercier, Alison
    Farrell, Daniel
    Rutz, Jennifer
    Bresz, Kellie
    Vernon, Tawnya
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2022, 35 (04) : 695 - 707
  • [44] Oral manifestations in mild-to-moderate cases of COVID-19 viral infection in the adult population
    Abubakr, Nermeen
    Salem, Zeinab Amin
    Kamel, Amany Hany Mohamed
    DENTAL AND MEDICAL PROBLEMS, 2021, 58 (01) : 7 - 15
  • [45] Effectiveness and Safety of Regdanvimab in Patients With Mild-To-Moderate COVID-19: A Retrospective Cohort Study
    Park, Susin
    Je, Nam Kyung
    Kim, Dong Wan
    Park, Miran
    Heo, Jeonghun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (13)
  • [46] Efficacy of Quinine Sulfate in Patients with Mild-To-Moderate COVID-19: A Randomized Controlled Trial
    Latarissa, Irma Rahayu
    Barliana, Melisa Intan
    Meiliana, Anna
    Sormin, Ida Paulina
    Sugiono, Erizal
    Kartasasmita, Cissy Bana
    Irmansyah
    Lestari, Keri
    INDONESIAN BIOMEDICAL JOURNAL, 2023, 15 (06): : 366 - 374
  • [47] Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India
    Josh, Shashank
    Vora, Agam
    Venugopal, K.
    Dadhich, Pramod
    Daxini, Anil
    Bhagat, Sagar
    Patil, Saiprasad
    Barkate, Hanmant
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2022, 13 : 33 - 41
  • [48] Real World Experience with Regdanvimab Treatment of Mild-to-Moderate Coronavirus Disease-19 in a COVID-19 Designated Hospital of Korea
    Hong, Sun In
    Ryu, Byung-Han
    Hong, Kyung-Wook
    Bae, In-Gyu
    Cho, Oh-Hyun
    INFECTION AND CHEMOTHERAPY, 2022, 54 (01): : 114 - 124
  • [49] Effectiveness of Integrative Medicine in COVID-19?
    Litscher, Gerhard
    MEDICAL ACUPUNCTURE, 2020, 32 (03) : 131 - 132
  • [50] Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
    Jerome R. Lechien
    Carlos M. Chiesa-Estomba
    Daniele R. De Siati
    Mihaela Horoi
    Serge D. Le Bon
    Alexandra Rodriguez
    Didier Dequanter
    Serge Blecic
    Fahd El Afia
    Lea Distinguin
    Younes Chekkoury-Idrissi
    Stéphane Hans
    Irene Lopez Delgado
    Christian Calvo-Henriquez
    Philippe Lavigne
    Chiara Falanga
    Maria Rosaria Barillari
    Giovanni Cammaroto
    Mohamad Khalife
    Pierre Leich
    Christel Souchay
    Camelia Rossi
    Fabrice Journe
    Julien Hsieh
    Myriam Edjlali
    Robert Carlier
    Laurence Ris
    Andrea Lovato
    Cosimo De Filippis
    Frederique Coppee
    Nicolas Fakhry
    Tareck Ayad
    Sven Saussez
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 2251 - 2261